Intelligent Bio Solutions Inc. (INBS) Cash from Financing Activities (2020 - 2025)

Intelligent Bio Solutions' Cash from Financing Activities history runs 5 years deep, the most recent figure standing at $3.3 million for Q1 2025.

• In Q1 2025, Cash from Financing Activities fell 69.16% year-over-year to $3.3 million; the TTM figure through Mar 2025 stood at $14.8 million (up 17.81% YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
• Cash from Financing Activities for Q1 2025 stood at $3.3 million, up from $631744.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $10.8 million in Q1 2024, with the low at $42450.0 in Q3 2024.
• The 4-year median for Cash from Financing Activities is $631744.0 (2024), against an average of $2.4 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 526.97% in 2024, then slumped 69.16% in 2025.
• Intelligent Bio Solutions' Cash from Financing Activities stood at $498100.0 in 2021, then tumbled by 90.74% to $46110.0 in 2023, then jumped by 1270.08% to $631744.0 in 2024, then jumped by 425.78% to $3.3 million in 2025.
• Business Quant data shows INBS's Cash from Financing Activities at $3.3 million in Q1 2025, $631744.0 in Q4 2024, and $42450.0 in Q3 2024.